Immunogenicity of Del19 EGFR mutations in Chinese patients affected by lung adenocarcinoma
出版年份 2019 全文链接
标题
Immunogenicity of Del19 EGFR mutations in Chinese patients affected by lung adenocarcinoma
作者
关键词
-
出版物
BMC IMMUNOLOGY
Volume 20, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-11-14
DOI
10.1186/s12865-019-0320-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial
- (2019) Martin Reck et al. Lancet Respiratory Medicine
- Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials
- (2018) Yi-Long Wu et al. Clinical Lung Cancer
- Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
- (2018) Mark A. Socinski et al. NEW ENGLAND JOURNAL OF MEDICINE
- EGFR TKI combination with immunotherapy in non-small cell lung cancer
- (2017) Myung-Ju Ahn et al. Expert Opinion On Drug Safety
- Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
- (2017) Samra Turajlic et al. LANCET ONCOLOGY
- EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer
- (2017) Zhong-Yi Dong et al. OncoImmunology
- Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategy
- (2016) Yoshihisa Kobayashi et al. CANCER SCIENCE
- EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis
- (2016) J. F. Gainor et al. CLINICAL CANCER RESEARCH
- Deep sequencing of the MHC region in the Chinese population contributes to studies of complex disease
- (2016) Fusheng Zhou et al. NATURE GENETICS
- FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy
- (2016) Dickran Kazandjian et al. ONCOLOGIST
- Cancer immunotherapy targeting neoantigens
- (2016) Yong-Chen Lu et al. SEMINARS IN IMMUNOLOGY
- Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
- (2016) Valsamo Anagnostou et al. Cancer Discovery
- Molecular basis of antibody binding to mucin glycopeptides in lung cancer
- (2015) JIN QU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Tumor neoantigens: building a framework for personalized cancer immunotherapy
- (2015) Matthew M. Gubin et al. JOURNAL OF CLINICAL INVESTIGATION
- Epidermal growth factor receptor derived peptide vaccination to prevent lung adenocarcinoma formation: An in vivo study in a murine model of EGFR mutant lung cancer
- (2015) Johnathan D. Ebben et al. MOLECULAR CARCINOGENESIS
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
- (2015) B. M. Carreno et al. SCIENCE
- Pancreatic cancer, treatment options, and GI-4000
- (2015) Marion L Hartley et al. Human Vaccines & Immunotherapeutics
- Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy
- (2015) Jashodeep Datta et al. Frontiers in Immunology
- Strong spontaneous tumor neoantigen responses induced by a natural human carcinogen
- (2015) Jenette Creaney et al. OncoImmunology
- Mismatch repair deficiency associated with complete remission to combination programmed cell death ligand immune therapy in a patient with sporadic urothelial carcinoma: immunotheranostic considerations
- (2015) Michael P. Castro et al. Journal for ImmunoTherapy of Cancer
- Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia
- (2014) M. Rajasagi et al. BLOOD
- Somatically mutated tumor antigens in the quest for a more efficacious patient-oriented immunotherapy of cancer
- (2014) Zlatko Trajanoski et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase II Study of the GI-4000 KRAS Vaccine After Curative Therapy in Patients With Stage I-III Lung Adenocarcinoma Harboring a KRAS G12C, G12D, or G12V Mutation
- (2014) Jamie E. Chaft et al. Clinical Lung Cancer
- Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity
- (2014) Fei Duan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Humoral Immune Responses to EGFR-Derived Peptides Predict Progression-Free and Overall Survival of Non-Small Cell Lung Cancer Patients Receiving Gefitinib
- (2014) Koichi Azuma et al. PLoS One
- High sensitivity of cancer exome-based CD8 T cell neo-antigen identification
- (2014) Marit M van Buuren et al. OncoImmunology
- The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study
- (2013) Peggy J. de Vos van Steenwijk et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cetuximab Response of Lung Cancer-Derived EGF Receptor Mutants Is Associated with Asymmetric Dimerization
- (2013) J. Cho et al. CANCER RESEARCH
- Mining the mutanome: developing highly personalized Immunotherapies based on mutational analysis of tumors
- (2013) Willem W Overwijk et al. Journal for ImmunoTherapy of Cancer
- Incidence ofEGFRExon 19 Deletions and L858R in Tumor Specimens From Men and Cigarette Smokers With Lung Adenocarcinomas
- (2011) Sandra P. D'Angelo et al. JOURNAL OF CLINICAL ONCOLOGY
- A comparison of ARMS and direct sequencing for EGFR mutation analysis and Tyrosine Kinase Inhibitors treatment prediction in body fluid samples of Non-Small-Cell Lung Cancer patients
- (2011) Yi Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Induction of Tumor-Specific CD4+ and CD8+ T-Cell Immunity in Cervical Cancer Patients by a Human Papillomavirus Type 16 E6 and E7 Long Peptides Vaccine
- (2008) M. J.P. Welters et al. CLINICAL CANCER RESEARCH
- EGF receptor variant III as a target antigen for tumor immunotherapy
- (2008) Gordon Li et al. Expert Review of Vaccines
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search